Alaunos Therapeutics Inc. Share Price

NASDAQ: TCRT

Small Cap

$2.25

-0.06

(-2.49%)

as on September 16, 2025 at 1:29 am IST

$₹

Alaunos Therapeutics Inc. Stock Performance

as on September 16, 2025 at 1:29 am IST

Day's Low
Day's High
$2.22
Day's Price Range
$2.4
$2.25
1.33%
Downside
6.67%
Upside
52 Week's Low
52 Week's High
$1.31
52-Week Price Range
$6.2
$2.25
41.61%
Downside
175.56%
Upside

Alaunos Therapeutics Inc. share price movements today

Previous Close: $2.31
Open: $2.39
Volume: 398.2K
Day's Low - High: $2.22 - $2.4
52 Week Low - High: $1.31 - $6.2

Alaunos Therapeutics Inc. Historical Returns

1 Month Return: 0 %
3 Month Return: -29.6 %
1 Year Return: + 4.65 %
3 Year Return: -99.4 %
5 Year Return: 0 %

Alaunos Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Alaunos Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.0M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-4.0M

Revenue (TTM)

6.0K

Profit Margin

0.00%

Return On Equity TTM

236900.00%

Alaunos Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Alaunos Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Alaunos Therapeutics Inc.	SELL	$5.0M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Stock Returns calculator for Alaunos Therapeutics Inc. Stock including INR - Dollar returns

The Alaunos Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Alaunos Therapeutics Inc. investment value today

Current value as on today

₹1,09,519

Returns

₹9,519

(+9.52%)

Returns from Alaunos Therapeutics Inc. Stock

₹4,651 (+4.65%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Alaunos Therapeutics Inc. Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Alaunos Therapeutics Inc.. Average target price of $1.75

Alaunos Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Alaunos Therapeutics Inc..

What analysts predicted

-28.57%DOWNSIDE

Target Price

$1.75

Current Price

$2.25

Analyzed by

6 Analysts

Target

$1.75

Alaunos Therapeutics Inc. target price $1.75, a slight downside of -28.57% compared to current price of $2.25. According to 6 analysts rating.

Alaunos Therapeutics Inc. Stock's Interest Amongst Investors

Search interest for Alaunos Therapeutics Inc. Stock has increased by 14% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:14% versus previous 30 day period

Alaunos Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	0	-	0	0	0	-	0	0	-
Gross Profit	0	-1	-1	-	0	0	0	0	0	-
Operating Income	-9	-7	-8	-3	-1	-1	-1	0	-1	-1
EBITDA	-8	-7	-7	-	-1	-1	-1	0	-1	-1
Interest Expense	0	1	-	-	3	-	-	-	-	-
Depreciation	0	0	0	0	0	0	-	0	-	-
Income Before Tax	-10	-8	-8	-7	-1	-1	-1	0	-1	-1
Income Tax Expense	0	1	0	-	0	-	-	-	0	-
Net Income	-9	-8	-8	-7	-1	-1	-1	0	-1	-1
Net Profit Margin	0.00%	-219325.00%	0.00%	-784300.00%	-168200.00%	-28225.00%	0.00%	-18550.00%	-53650.00%	0.00%

Alaunos Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	4	6	6	0	-	-	0	2	0	0
Gross Profit	4	6	6	0	0	-1	0	0	-4	0
Operating Income	-120	-165	-53	-53	2	-80	-77	-35	-34	-4
EBITDA	-119	-165	-53	-53	-117	-79	-74	-31	-30	-4
Interest Expense	0	0	0	0	120	0	1	3	1	-
Depreciation	-	-	-	0	0	1	2	2	2	0
Income Before Tax	-120	-165	-54	-53	-117	-79	-78	-37	-35	-4
Income Tax Expense	0	0	2	0	60	-1	-1	0	2	-
Net Income	-120	-165	-54	-53	-177	-78	-76	-37	-35	-4
Net Profit Margin	-2772.11%	-2409.23%	-850.26%	-36381.51%	0.00%	0.00%	-19320.10%	-1286.69%	-702800.00%	-46790.00%

Alaunos Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-8	-8	-7	-1	-1	41	0	-1	20
Operating Cash Flow	-7	-6	-7	-1	-1	26	0	0	0
Investing Cash Flow	0	0	-	1	-	2	-	-2	0
Financing Cash Flow	-11	-	-	-	-	-24	-	-	3
Change in Cash	-19	-6	-5	-1	-1	0	0	0	2

Alaunos Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-165	-54	-53	-117	-79	-78	-37	-35	-4
Operating Cash Flow	-58	-54	-49	-40	-57	-61	-29	-30	-4
Investing Cash Flow	0	0	0	0	-9	-3	0	1	-
Financing Cash Flow	0	45	40	59	102	25	6	-18	-
Change in Cash	-59	-10	-9	18	35	-39	-23	-46	-4

Global Institutional Holdings in Alaunos Therapeutics Inc.

Funds	Holdings
BlackRock Inc	1.3%
Vanguard Group Inc	1.28%
Geode Capital Management, LLC	0.95%
UBS Group AG	0.48%
Tower Research Capital LLC	0.1%

See all

Insights on Alaunos Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -1.07M → -1.05M (in $), with an average increase of 2.1% per quarter
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 215.9%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 65.9%
NEGATIVE IMPACT
Price Dip
In the last 3 months, TCRT stock has moved down by -29.6%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 4.0K → 2.0K (in $), with an average decrease of 50.0% per quarter

About Alaunos Therapeutics Inc.

ziopharm oncology, inc., is a biopharmaceutical company focused on the discovery and development of new cancer therapies. we are applying the latest technologies in cancer research to develop safer, more precise therapeutics to improve care and quality of life for patients.

Organisation	Alaunos Therapeutics Inc.
Headquarters	2617 Bissonnet Street, Houston, TX, United States, 77005
Industry	Healthcare
CEO	Mr. Holger Weis CPA
E-voting on shares	Click here to vote

Key Management of Alaunos Therapeutics Inc.

Name	Title
Mr. Ferdinand Groenewald	Vice President of Finance
Mr. Holger Weis CPA	Chairman of the Board & CEO

FAQs

What is Alaunos Therapeutics Inc. share price today?

Alaunos Therapeutics Inc. share price today is $2.25 as on September 16, 2025 at 1:29 am IST at the close of the market. Alaunos Therapeutics Inc. share today touched a day high of $2.4 and a low of $2.22.

What is the 52 week high and 52 week low for Alaunos Therapeutics Inc. share?

Alaunos Therapeutics Inc. share touched a 52 week high of $6.2 on July 14, 2025 and a 52 week low of $1.31 on March 31, 2025. Alaunos Therapeutics Inc. stock price today i.e. September 16, 2025 at 1:29 am IST is closed at $2.25,which is 63.71% down from its 52 week high and 71.27% up from its 52 week low.

What is Alaunos Therapeutics Inc.'s market capitalisation today?

Alaunos Therapeutics Inc. market capitalisation is $0.00T as on September 16, 2025 at 1:29 am IST.

How to invest in Alaunos Therapeutics Inc. Stock (TCRT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Alaunos Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Alaunos Therapeutics Inc. Shares that will get you 0.6667 shares as per Alaunos Therapeutics Inc. share price of $2.25 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Alaunos Therapeutics Inc. Stock (TCRT) from India?

Indian investors can start investing in Alaunos Therapeutics Inc. (TCRT) shares with as little as ₹88.042 or $1 (as of September 16, 2025 at 5:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Alaunos Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 5:40 pm IST). Based on Alaunos Therapeutics Inc. share’s latest price of $2.25 as on September 16, 2025 at 1:29 am IST, you will get 4.4444 shares of Alaunos Therapeutics Inc.. Learn more about fractional shares .